Exheus, the company located at the TecnoCampus and a member of CataloniaBio & HealthTech, specialised in the analysis of gene expression using artificial intelligence (AI), has announced the launch of Beyond You. This new brand is accompanied by a digital platform that will provide healthcare professionals with personalised information to optimise the diagnosis and treatment of their patients.
With the new digital transcriptomics platform based on mRNA analysis, health professionals can have control of a whole range of precision biomarkers to speed up diagnosis and monitor the treatment of their patients in a personalised way.
"The change to Beyond You reflects our commitment to a collaborative approach. By joining with health professionals, we are building a solid network of shared knowledge and expertise. Together, we can leverage our expertise in genetic analysis and inflammation monitoring to develop more effective and personalised solutions," says CSO Dr José Manuel Soria.
This new strategic approach aims to provide users with a comprehensive view of how their blood is being activated and, at the same time, help health professionals to make informed and personalised decisions in the field of disease treatment and prevention. Currently, under the Beyond You brand, the technology is being applied in clinical studies to monitor inflammation and other alterations related to poor lifestyle habits and the stress caused to the body in certain circumstances, in many cases leading to chronic diseases.
Beyond You also announces that it is preparing a new round of funding with the aim of obtaining CE certification for its innovative transcriptomic test.
Comments